Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
784.7 INR | +1.24% | +3.58% | +20.86% |
Sales 2024 * | 41.14B 494M | Sales 2025 * | 45.13B 542M | Capitalization | 71.23B 855M |
---|---|---|---|---|---|
Net income 2024 * | -414M -4.97M | Net income 2025 * | 2.92B 35.05M | EV / Sales 2024 * | 1.73 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.58 x |
P/E ratio 2024 * |
-169
x | P/E ratio 2025 * |
19.1
x | Employees | 2,850 |
Yield 2024 * |
0.46% | Yield 2025 * |
0.46% | Free-Float | 66.98% |
Latest transcript on Strides Pharma Science Limited
1 day | +1.24% | ||
1 week | +3.58% | ||
Current month | -0.24% | ||
1 month | +0.27% | ||
3 months | +21.90% | ||
6 months | +56.25% | ||
Current year | +20.86% |
Managers | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 90-06-27 |
Badree Komandur
DFI | Director of Finance/CFO | - | 10-01-31 |
Compliance Officer | - | 17-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 90-06-27 |
Director/Board Member | 80 | 17-05-17 | |
Director/Board Member | 63 | 12-07-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 115 M€ | +4.54% | - | |
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 784.7 | +1.24% | 181 338 |
24-03-27 | 775.1 | +0.33% | 227,405 |
24-03-26 | 772.6 | -0.59% | 342,333 |
24-03-22 | 777.2 | +2.59% | 207,468 |
24-03-21 | 757.6 | -0.57% | 153,468 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.86% | 855M | |
+28.67% | 46.19B | |
+18.57% | 22.88B | |
+20.11% | 14.18B | |
-0.48% | 12.63B | |
+46.16% | 12.07B | |
-1.55% | 7.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.37% | 5.14B |